About the Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian Session
Solid tumors encompass a diverse range of cancers affecting specific organs and tissues. Breast and prostate cancers are highly prevalent, with ongoing advancements in targeted therapies and hormonal treatments improving patient outcomes. Lung cancer research focuses on personalized medicine, utilizing biomarkers to tailor treatments. Colorectal cancer studies emphasize the role of gut microbiota and immunotherapy in disease progression and treatment. Pancreatic cancer remains one of the most lethal forms, with efforts directed toward early detection and innovative therapies. Liver cancer research highlights the significance of antiviral treatments in hepatitis-associated cases. Ovarian cancer advancements include precision surgery and novel chemotherapy regimens. These research areas collectively aim to enhance survival rates and improve the quality of life for cancer patients.
Topics Covered in Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian
Breast & Ovarian Cancer
Lung Cancer Biomarkers
Colorectal Screening
Prostate Hormone Therapy
Pancreatic Early Detection
Liver Cancer Therapies
Related Scientific Sessions at CIOC 2027
Why Attend the Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian Conference 2027 — FAQs
What is the Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian track at CIOC 2027?
The Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian sessions?
Cancer researchers and clinicians, educators and students with an interest in Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian are all welcome — whether presenting or attending.
Can I present my research in the Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.